Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

252
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
252
Long-term Depression01:05

Long-term Depression

33.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.3K
Pilot and Numeric Relaying01:21

Pilot and Numeric Relaying

496
Pilot relaying is a type of differential protection used in power systems. It compares electrical quantities at the terminals of equipment via a communication channel instead of direct relay interconnection. This method is essential for transmission lines where the terminals are far apart, typically up to 80 km for lines with 69 to 115 kV ratings. Four types of communication channels are used for pilot relaying:
496
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

40.1K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.1K
Depressants01:28

Depressants

429
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
429
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

472
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
472

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Xanomeline/trospium and suicide-related events in schizophrenia: An early pharmacovigilance analysis.

Schizophrenia research·2026
Same author

Depressed mood and suicidal thoughts reporting with GLP-1 receptor agonists in type 2 diabetes: A WHO VigiBase study.

Journal of affective disorders·2026
Same author

Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled Trial.

Schizophrenia bulletin open·2024
Same author

Distinct homotopic functional connectivity patterns of the amygdalar sub-regions as biomarkers in major depressive disorder.

Journal of affective disorders·2024
Same author

Individuals vary in their overt attention preference for positive images consistently across time and stimulus types.

Scientific reports·2024
Same author

An evaluation of treatment response and remission definitions in adult obsessive-compulsive disorder: A systematic review and individual-patient data meta-analysis.

Journal of psychiatric research·2024

Related Experiment Video

Updated: Feb 1, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K

Ropinirole Augmentation for Depression: A Randomized Controlled Trial Pilot Study.

Ari A Gershon, Revital Amiaz, Haim Shem-David

  • 1Jerusalem Mental Health Center, Jerusalem, Israel.

Journal of Clinical Psychopharmacology
|November 30, 2018
PubMed
Summary
This summary is machine-generated.

Add-on ropinirole did not improve depression symptoms in patients unresponsive to standard antidepressants. This study found no significant difference compared to placebo, suggesting ropinirole may not be an effective antidepressant.

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.9K

Related Experiment Videos

Last Updated: Feb 1, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.9K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Dopaminergic pathways are implicated in depression treatment.
  • Ropinirole, a dopamine D2/D3 agonist, is used for Parkinson's disease.
  • Preliminary data suggested potential antidepressant effects of dopamine agonists.

Purpose of the Study:

  • To evaluate the efficacy of add-on ropinirole in patients with treatment-resistant depression.
  • To determine if ropinirole improves depressive symptoms when added to existing antidepressant medication.

Main Methods:

  • A double-blind, randomized, placebo-controlled trial was conducted.
  • 32 patients with persistent depression despite adequate antidepressant treatment were enrolled.
  • Patients received either 2 mg oral ropinirole or placebo twice daily for 7 weeks.

Main Results:

  • No statistically significant differences were observed in primary or secondary outcome measures between the ropinirole and placebo groups.
  • Hamilton Depression Rating Scale and Montgomery-Asberg Depression Rating Scale scores did not improve more with ropinirole.

Conclusions:

  • Add-on ropinirole was not effective in treating patients with major depression unresponsive to standard antidepressants.
  • The findings contrast with previous studies and theoretical expectations.
  • Differences in pharmacological activity compared to other dopaminergic agents like pramipexole may explain these results.